Kabra Drugs will hold a meeting of the Board of Directors of the Company on 7 March 2026.Powered by Capital Market - Live News

Net profit of Kabra Drugs reported to Rs 2.57 crore in the quarter ended December 2025 as against net loss of Rs 0.54 crore during the previous quarter ended December 2024. Sales reported to Rs 30.42 crore in the quarter ended December 2025. There were no Sales reported during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales30.420 0 OPM %8.020 - PBDT2.62-0.54 LP PBT2.61-0.54 LP NP2.57-0.54 LP Powered by Capital Market - Live News

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live News

Kabra Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 26 December 2025.Powered by Capital Market - Live News

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 28 November 2025.Powered by Capital Market - Live News